Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1996-11-21
2000-02-15
Achutamurthy, Ponnathapu
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 13, 424 49, 424401, 424413, 424440, 530324, 530325, 530326, 435 691, 4352523, 4353201, A61K 716, A61K 968, C07K 708, C07K 702
Patent
active
060253266
ABSTRACT:
The present invention provides methods and compositions suitable for treating oral mucositis in animals, including humans, with antimicrobial peptides such as protegrin peptides.
REFERENCES:
patent: 4323694 (1982-04-01), Scala, Jr.
patent: 4543252 (1985-09-01), Lehrer et al.
patent: 4652639 (1987-03-01), Stabinsky
patent: 4659692 (1987-04-01), Lehrer et al.
patent: 4705777 (1987-11-01), Lehrer et al.
patent: 5059416 (1991-10-01), Cherukuri et al.
patent: 5087569 (1992-02-01), Gabay et al.
patent: 5102870 (1992-04-01), Florine et al.
patent: 5126257 (1992-06-01), Gabay et al.
patent: 5171739 (1992-12-01), Scott et al.
patent: 5234912 (1993-08-01), Marra et al.
patent: 5308834 (1994-05-01), Scott et al.
patent: 5334584 (1994-08-01), Scott et al.
patent: 5338724 (1994-08-01), Gabay et al.
patent: 5432270 (1995-07-01), Zasloff et al.
patent: 5447914 (1995-09-01), Travis et al.
patent: 5458874 (1995-10-01), Pereira et al
patent: 5459235 (1995-10-01), Selsted et al.
patent: 5464823 (1995-11-01), Lehrer et al.
patent: 5484885 (1996-01-01), Pereira et al.
patent: 5486503 (1996-01-01), Oppenheim et al.
patent: 5607916 (1997-03-01), Pereira et al.
patent: 5614545 (1997-03-01), Martin et al.
patent: 5631228 (1997-05-01), Oppenheim et al.
patent: 5693486 (1997-12-01), Lehrer et al.
patent: 5708145 (1998-01-01), Lehrer et al.
Bateman et al., 1992, "The levels and biologic action of the human neutrophil granule peptide HP-1 in lung tumors," Peptides 13:133-139.
Bilgrami, S. et al., 1992, "Capnocytophage Bacteremia in Patient with Hodgkin's Disease following Bone Marrow Transplantion: Case Report and Review," Clinical Infectious Diseases 14:1045-1049.
Broekaert et al., 1992, Biochemistry 31:4308-4314.
Cornelissen et al., 1993, Plant Physiol. 101:709-712.
Diamond et al., 1991, Proc. Natl. Acad. Sci. U.S.A. 88:3952-3956.
Donnelley, J.P. et al., 1993, "Failure of Clindamycin to Influence the Course of Severe Oromucositis Associated with Steptococcal Bactaeremia in Allogeneic Bone Marrow Transplant Recipients," Scand. J. Infect. Dis. 25:43-50.
Elsbach et al., 1993, Current Opinion in Immunology 5:103-107.
Haln et al., 1993, Nature 361:153-156.
Harwig et al., 1994, "Gallacins: cysteine-rich antimicrobial peptides of chicken leukocytes," FEBS Lett. 342:281-285.
Harwig et al., 1995, J. Peptide Sci. 3:207-215.
Harwig et al., 1995, FEBS Lett. 362:65-69.
Hoess et al., 1993, EMBO Journal 12:3351-3356.
Kokryakov et al., 1993, FEBS Lett. 327:231-236.
Lambert et al., 1989, Proc. Natl. Acad. Sci. U.S.A. 88:262-265.
Lehrer et al., 1985, J. Virol. 54:467-472.
Lehrer et al., 1991, Cell 64:229-230.
Lehrer et al., 1993, Ann. Rev. Immunol. 11:105-128.
Lerner, 1982, Nature 289:592-596.
Maloy & Kari, 1995, "Structure-activity studies on maganins and other host defense peptides," Biopolymers (Peptide Science) 37:105-122.
Masera et al., 1996, "Corticostatins/defensins inhibit in vitro NK activity and cytokine production by human peripheral blood mononuclear cells," Regulatory Peptides 62:13-21.
Masuda et al., 1992, "A novel anti-HIV synthetic peptide T-22 ([Tyr5, 12, Lys7]-polyphemusin II)," Biochem. Biophys. Res. Commun. 189:845-850.
Matsumoto et al., 1982, Chem. and Pharma. Bulletin 40(10):2701-2706.
Matsuzaki et al., 1991, "Interactions of an antimicrobial peptide, tachyplesin I, with lipid membranes," Biochim. Biophys. Acta 1070:259-264.
Matsuzaki et al., 1993, Biochemistry 32:11704-11710.
Mirgorodskaya et al., 1993, FEBS Lett. 330:339-342.
Miyata et al., 1989, J. Biochem. 106:663-668.
Morimoto et al., 1991, Chemotherapy 37:206-211.
Murakami et al., 1991, Chemotherapy 37:327-334.
Nakamura et al., 1988, J. Biol. Chem. 263:16709-16713.
Nakashima et al., 1992, Antimicrobial Agents and Chemotherapy pp. 1249-1255.
Olsson et al., 1991, Biochim. Biophys. Acta. 1097:37-44.
Park et al., 1992, "Conformation of tachyplesin I from Tachypleus tridentatus when interacting with lipid matrices," Biochemistry 31:12241-12247.
Pongor et al., 1987, Methods in Enzymology 154:450-473.
Robson et al., 1986, Introduction to Proteins and Protein Engineering, Elksevier, New York, p. 41.
Rustici et al., 1993, Science 259:361-364.
Schluesener et al., 1993, "Leukocyte antimicrobial peptides kill autoimmune T cells," Journal of Neuroimmunology 47:199-202.
Selsted et al., 1985, J. Biol. Chem. 260(8):4579-4584.
Selsted et al., 1992, "Enteric defensins: Antibiotic peptide components of intestinal host defense," J. Celll Biol. 118:929-936.
Selsted et al., 1993, J. Biol. Chem. 268:6641-6648.
Storici et al., 1993, Biochem. Biophys. Res. Commun. 196:1363-1368.
Tamamura et al., 1993, "Antimicrobial activity and conformation of tachyplesin I and its analogs," Chemical and Pharmaceutical Bulletin 41:978-980.
Tamamura et al., 1993, "A comparative study of the solution structure of tachyplesin I and a novel anti-HIV synthetic peptide, T22, determined by nuclear magnetic resonance," Biochim. Biophys. Acta 1163:209-216.
Tamamura et al., 1995, "Synthesis of protegrin-related peptides and their antibacterial and anti-Human Immunodeficiency Virus activity," Chemical and Pharmaceutical Bulletin 43:853-858.
Zhao et al., 1994, FEBS Lett. 346:285-288.
Zhao et al., 1995, FEBS Lett. 368:197-202.
Zhao et al., 1995, FEBS Lett. 376:130-134.
Harwig S. S. L. et al., 1996, "Intramolecular disulfide bonds enhance the antimicrobial and lytic activities of protegrins at physiological sodium chloride concentrations," Eur. J. Biochem. 240:352-357.
Yasin, B. et al., 1996, "Protegrins: Structural requirements for inactivating elementary bodies of Chlamydia trachomatis," Infection and Immunity 64(11):4863-4866.
Simmaco, M., et al., The Journal of Biological Chemistry, vol. 269, "Antimicrobial peptides from skin secretions of Rana esculenta", pp. 11956-11961, 1994.
Foote, R. L., et al., Journal of Clinical Oncology, vol. 12, "Randomized trial of a chlorhexidine mouthwash for alleviation of radiation-induced mucositis", pp. 2630-2633, 1994.
Epstein, J. B., et al., Oral Surgery, Oral Medicine and Oral Pathology, vol. 73, "Efficacy of chlorhexidine and nystatin rinses in prevention or oral complications in leukemia and bone marrow transplantation", pp. 682-689, 1992.
Donnelly, J. P., et al., Scandinavina Journal of Infectious Diseases, vol. 25, "Failure of clindamycin to influence the course of severe oromucositis associated wtih strptococcal bacteraemia in allogeneic bone marrow transplant recipients", pp. 43-50, 1993.
Chang Conway C.
Chao De Hwa
Fiddes John C.
Fu Roger Cherng
Gu Chee Liang
Achutamurthy Ponnathapu
IntraBiotics Pharmaceuticals, Inc.
Moore William W.
LandOfFree
Compositions and methods for the prevention and treatment of ora does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for the prevention and treatment of ora, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for the prevention and treatment of ora will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1905930